LumiThera Inc. have announced a multi-centre registry (“EUROLIGHT”) for their photo-biomodulation (PBM) treatment of dry AMD across up to 20 European centres.
A US company, LumiThera Inc., based in Seattle, WA, has announced a multi-centre clinical registry study to enroll up to 1,000 AMD patients with their… Read More »LumiThera Inc. have announced a multi-centre registry (“EUROLIGHT”) for their photo-biomodulation (PBM) treatment of dry AMD across up to 20 European centres.